Silence Therapeutics plc Increase Through New Leases Liabilities Arising From Financing Activities
Silence Therapeutics plc (SLNCF) reported Increase Through New Leases Liabilities Arising From Financing Activities of GBP 499.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities · last filed 2023-03-15
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2022-12-31 | 499.00K GBP 20-F · filed 2023-03-15 |
| 2021-12-31 | 7.00K GBP 20-F · filed 2022-03-17 |
| 2020-12-31 | 456.00K GBP 20-F/A · filed 2021-04-29 |